Literature DB >> 9008633

Models of open-angle glaucoma prevalence and incidence in the United States.

H A Quigley1, S Vitale.   

Abstract

PURPOSE: To estimate the prevalence and incidence of open-angle glaucoma among black and white persons in the United States and to characterize quantitatively their life experience with glaucoma using a life table approach to estimate disease duration.
METHODS: Review of published data on glaucoma combined with statistical models to estimate prevalence and incidence.
RESULTS: The association of open-angle glaucoma with age was examined separately for white and black persons. By the year 2000, the number of persons in the United States with primary open-angle glaucoma is estimated to be 2.47 million (1.84 million white and 619,000 black Americans). A model using derived incidence rates for open-angle glaucoma (OAG) and United States mortality data indicated that the average black American has OAG 27% longer than the average white American (16.3 years compared to 12.8 years).
CONCLUSIONS: Meta-analysis to obtain pooled prevalence estimates for glaucoma provides useful information on length of disease and age distribution of those affected. It may assist in estimating treatment effects and associated costs to derive data that effect health care decisions.

Entities:  

Mesh:

Year:  1997        PMID: 9008633

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  101 in total

1.  The impact of new drugs on management of glaucoma in Scotland: observational study.

Authors:  D N Bateman; R Clark; A Azuara-Blanco; M Bain; J Forrest
Journal:  BMJ       Date:  2001-12-15

2.  The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care.

Authors:  D N Bateman; R Clark; A Azuara-Blanco; M Bain; J Forrest
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

3.  Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UK.

Authors:  D C Minassian; A Reidy; M Coffey; A Minassian
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

4.  Relationship Between Fuchs Endothelial Corneal Dystrophy Severity and Glaucoma and/or Ocular Hypertension.

Authors:  Mehul Nagarsheth; Annapurna Singh; Brian Schmotzer; Denise C Babineau; Joel Sugar; W Barry Lee; Sudha K Iyengar; Jonathan H Lass
Journal:  Arch Ophthalmol       Date:  2012-11

Review 5.  Seeing into the future. Vision and aging.

Authors:  R E Kalina
Journal:  West J Med       Date:  1997-10

6.  The 'two global flash' mfERG in high and normal tension primary open-angle glaucoma.

Authors:  Anja M Palmowski-Wolfe; Margarita G Todorova; Selim Orguel; Josef Flammer; Mitchell Brigell
Journal:  Doc Ophthalmol       Date:  2006-12-08       Impact factor: 2.379

Review 7.  Extracellular matrix in the trabecular meshwork.

Authors:  Ted S Acott; Mary J Kelley
Journal:  Exp Eye Res       Date:  2008-01-25       Impact factor: 3.467

Review 8.  How the diabetic eye loses vision.

Authors:  Jaime A Davidson; Thomas A Ciulla; Janet B McGill; Keri A Kles; Pamela W Anderson
Journal:  Endocrine       Date:  2007-09-27       Impact factor: 3.633

9.  Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function.

Authors:  B S Kim; O V Savinova; M V Reedy; J Martin; Y Lun; L Gan; R S Smith; S I Tomarev; S W John; R L Johnson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity.

Authors:  L Carli; C Tani; F Querci; A Della Rossa; S Vagnani; C Baldini; R Talarico; A d'Ascanio; R Neri; A G Tavoni; S Bombardieri; M Mosca
Journal:  Clin Rheumatol       Date:  2013-03-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.